MEDNAX (MD) Set to Announce Quarterly Earnings on Monday

MEDNAX (NYSE:MD) is scheduled to announce its earnings results before the market opens on Monday, February 5th.

MEDNAX (NYSE:MD) opened at $54.76 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.62. MEDNAX has a 1 year low of $40.56 and a 1 year high of $72.13. The stock has a market capitalization of $5,130.00, a P/E ratio of 19.42, a P/E/G ratio of 1.54 and a beta of 0.39.

In other MEDNAX news, Director Cesar L. Alvarez sold 10,668 shares of the business’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $42.59, for a total value of $454,350.12. Following the sale, the director now directly owns 44,215 shares in the company, valued at $1,883,116.85. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $51.58, for a total value of $154,740.00. Following the completion of the sale, the insider now owns 35,569 shares in the company, valued at $1,834,649.02. The disclosure for this sale can be found here. Insiders own 2.40% of the company’s stock.

Several research firms have weighed in on MD. Mizuho set a $49.00 price objective on MEDNAX and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Stifel Nicolaus reissued a “hold” rating and issued a $56.00 price objective on shares of MEDNAX in a research report on Wednesday, January 24th. Zacks Investment Research raised MEDNAX from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a research report on Tuesday, January 23rd. SunTrust Banks set a $55.00 price objective on MEDNAX and gave the stock a “hold” rating in a research report on Thursday, December 21st. Finally, Piper Jaffray Companies began coverage on MEDNAX in a research report on Wednesday, December 13th. They issued an “overweight” rating and a $58.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $54.25.

ILLEGAL ACTIVITY WARNING: “MEDNAX (MD) Set to Announce Quarterly Earnings on Monday” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/01/29/mednax-md-set-to-announce-quarterly-earnings-on-monday.html.

About MEDNAX

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Earnings History for MEDNAX (NYSE:MD)

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply